| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Percutaneous Coronary Intervention | 27 | 2021 | 3646 | 3.39 | Why? |
| Atherectomy | 4 | 2017 | 8 | 2.35 | Why? |
| Cardiac Catheterization | 8 | 2020 | 882 | 2.18 | Why? |
| Coronary Artery Disease | 9 | 2018 | 2570 | 1.99 | Why? |
| Angioplasty, Balloon | 4 | 2018 | 66 | 1.74 | Why? |
| Coronary Angiography | 19 | 2020 | 2275 | 1.73 | Why? |
| Radiography, Interventional | 6 | 2018 | 158 | 1.57 | Why? |
| Peripheral Arterial Disease | 5 | 2018 | 471 | 1.56 | Why? |
| Coronary Occlusion | 11 | 2018 | 138 | 1.56 | Why? |
| Vascular Calcification | 5 | 2017 | 396 | 1.36 | Why? |
| Robotics | 3 | 2017 | 528 | 1.28 | Why? |
| Robotic Surgical Procedures | 3 | 2018 | 787 | 1.18 | Why? |
| Femoral Artery | 2 | 2017 | 213 | 1.18 | Why? |
| Hypertension, Pulmonary | 3 | 2018 | 970 | 1.11 | Why? |
| Cardiology | 6 | 2020 | 2873 | 0.93 | Why? |
| Coronary Vessels | 6 | 2018 | 914 | 0.91 | Why? |
| Atherectomy, Coronary | 2 | 2018 | 35 | 0.89 | Why? |
| Registries | 19 | 2021 | 12327 | 0.88 | Why? |
| Endovascular Procedures | 4 | 2018 | 1302 | 0.87 | Why? |
| Iliac Artery | 2 | 2018 | 50 | 0.86 | Why? |
| Radiation Protection | 2 | 2018 | 78 | 0.86 | Why? |
| Vascular System Injuries | 2 | 2018 | 91 | 0.86 | Why? |
| Electrophysiologic Techniques, Cardiac | 2 | 2020 | 396 | 0.78 | Why? |
| Heart Septum | 1 | 2017 | 29 | 0.72 | Why? |
| Fibromuscular Dysplasia | 1 | 2017 | 9 | 0.72 | Why? |
| Endarterectomy | 1 | 2018 | 60 | 0.72 | Why? |
| Hypertension, Renovascular | 1 | 2017 | 14 | 0.72 | Why? |
| Lasers, Excimer | 1 | 2018 | 37 | 0.72 | Why? |
| Vascular Fistula | 1 | 2017 | 22 | 0.71 | Why? |
| Renal Artery Obstruction | 1 | 2017 | 27 | 0.70 | Why? |
| Coronary Sinus | 1 | 2017 | 41 | 0.69 | Why? |
| Societies, Medical | 8 | 2020 | 6907 | 0.68 | Why? |
| Heart Aneurysm | 1 | 2017 | 46 | 0.68 | Why? |
| Cardiovascular Agents | 3 | 2018 | 663 | 0.67 | Why? |
| Myocardial Revascularization | 1 | 2019 | 267 | 0.66 | Why? |
| Sphingolipids | 1 | 2017 | 59 | 0.65 | Why? |
| Peripheral Vascular Diseases | 1 | 2018 | 133 | 0.64 | Why? |
| Stents | 4 | 2018 | 916 | 0.64 | Why? |
| Cardiology Service, Hospital | 2 | 2020 | 602 | 0.63 | Why? |
| Myocardial Infarction | 5 | 2020 | 3361 | 0.62 | Why? |
| Secondary Prevention | 2 | 2018 | 762 | 0.62 | Why? |
| Coronary Restenosis | 1 | 2017 | 153 | 0.59 | Why? |
| Foramen Ovale, Patent | 1 | 2018 | 153 | 0.59 | Why? |
| Fractional Flow Reserve, Myocardial | 1 | 2017 | 173 | 0.59 | Why? |
| Phospholipids | 1 | 2017 | 202 | 0.58 | Why? |
| Surgery, Computer-Assisted | 1 | 2017 | 183 | 0.57 | Why? |
| Protective Clothing | 1 | 2018 | 468 | 0.57 | Why? |
| Drug-Eluting Stents | 2 | 2018 | 562 | 0.56 | Why? |
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 341 | 0.54 | Why? |
| Acute Coronary Syndrome | 2 | 2018 | 2107 | 0.54 | Why? |
| Antithrombins | 1 | 2018 | 353 | 0.54 | Why? |
| Postoperative Complications | 5 | 2017 | 5861 | 0.51 | Why? |
| ST Elevation Myocardial Infarction | 5 | 2021 | 3051 | 0.49 | Why? |
| Cardiovascular Surgical Procedures | 3 | 2020 | 281 | 0.49 | Why? |
| Treatment Outcome | 27 | 2020 | 51732 | 0.46 | Why? |
| Fibrinogen | 1 | 2017 | 1048 | 0.46 | Why? |
| Heart Ventricles | 2 | 2017 | 1139 | 0.39 | Why? |
| Equipment Contamination | 1 | 2018 | 1308 | 0.39 | Why? |
| Lung Injury | 1 | 2018 | 919 | 0.38 | Why? |
| Ultraviolet Rays | 1 | 2018 | 1272 | 0.38 | Why? |
| Pulmonary Embolism | 2 | 2018 | 4775 | 0.36 | Why? |
| Thrombolytic Therapy | 1 | 2020 | 2218 | 0.36 | Why? |
| Cardiac Surgical Procedures | 2 | 2020 | 1931 | 0.35 | Why? |
| Angiography | 3 | 2018 | 301 | 0.35 | Why? |
| Cross Infection | 3 | 2020 | 8675 | 0.34 | Why? |
| Leadership | 3 | 2020 | 2241 | 0.34 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.33 | Why? |
| Consensus | 3 | 2020 | 6345 | 0.33 | Why? |
| Fibrinolytic Agents | 1 | 2018 | 1702 | 0.32 | Why? |
| Time Factors | 17 | 2019 | 31397 | 0.32 | Why? |
| Vascular Access Devices | 2 | 2018 | 122 | 0.31 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.31 | Why? |
| Radiation Injuries | 2 | 2018 | 140 | 0.31 | Why? |
| Radiation Exposure | 2 | 2018 | 161 | 0.30 | Why? |
| Cardiovascular Diseases | 3 | 2020 | 11497 | 0.30 | Why? |
| Disinfection | 1 | 2018 | 2912 | 0.29 | Why? |
| Diffusion of Innovation | 2 | 2019 | 440 | 0.29 | Why? |
| Intraoperative Complications | 2 | 2017 | 221 | 0.28 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.28 | Why? |
| Heparin | 1 | 2018 | 2600 | 0.28 | Why? |
| Chronic Disease | 12 | 2018 | 5139 | 0.28 | Why? |
| United States | 22 | 2021 | 46150 | 0.28 | Why? |
| Angioplasty, Balloon, Coronary | 2 | 2018 | 365 | 0.26 | Why? |
| Feasibility Studies | 3 | 2018 | 3467 | 0.26 | Why? |
| Cardiologists | 2 | 2018 | 366 | 0.24 | Why? |
| Humans | 64 | 2021 | 930598 | 0.23 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.23 | Why? |
| Risk Factors | 20 | 2019 | 71621 | 0.23 | Why? |
| Female | 40 | 2021 | 380317 | 0.21 | Why? |
| Vascular Patency | 2 | 2018 | 96 | 0.21 | Why? |
| Transcatheter Aortic Valve Replacement | 2 | 2020 | 839 | 0.21 | Why? |
| Hyperlipoproteinemias | 1 | 2019 | 7 | 0.20 | Why? |
| Aged | 26 | 2021 | 215776 | 0.20 | Why? |
| Bundle-Branch Block | 1 | 2020 | 127 | 0.19 | Why? |
| Predictive Value of Tests | 4 | 2019 | 9537 | 0.19 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 144 | 0.19 | Why? |
| Infection Control | 4 | 2020 | 23131 | 0.19 | Why? |
| Enzyme Activators | 1 | 2018 | 24 | 0.19 | Why? |
| Male | 37 | 2021 | 367725 | 0.19 | Why? |
| Operative Time | 2 | 2017 | 450 | 0.19 | Why? |
| Heart Diseases | 3 | 2020 | 3503 | 0.18 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.18 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.18 | Why? |
| Septal Occluder Device | 1 | 2018 | 46 | 0.18 | Why? |
| Radioisotope Dilution Technique | 1 | 2017 | 2 | 0.18 | Why? |
| Assisted Circulation | 1 | 2018 | 30 | 0.18 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.18 | Why? |
| Equipment Design | 3 | 2018 | 3095 | 0.18 | Why? |
| Mammary Arteries | 1 | 2017 | 31 | 0.18 | Why? |
| Lipoprotein(a) | 1 | 2019 | 92 | 0.18 | Why? |
| Lens, Crystalline | 1 | 2017 | 14 | 0.18 | Why? |
| Hirudins | 1 | 2018 | 75 | 0.18 | Why? |
| Popliteal Artery | 1 | 2017 | 32 | 0.17 | Why? |
| Cardiac Catheters | 1 | 2017 | 44 | 0.17 | Why? |
| Organizational Objectives | 1 | 2019 | 180 | 0.17 | Why? |
| Cardiac Imaging Techniques | 1 | 2020 | 357 | 0.17 | Why? |
| Fluoroscopy | 1 | 2017 | 140 | 0.17 | Why? |
| Survival Rate | 4 | 2020 | 9206 | 0.17 | Why? |
| Angioplasty | 1 | 2017 | 106 | 0.16 | Why? |
| Risk Assessment | 7 | 2020 | 25439 | 0.16 | Why? |
| Practice Patterns, Physicians' | 4 | 2020 | 4927 | 0.16 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.16 | Why? |
| Ventricular Fibrillation | 1 | 2017 | 126 | 0.16 | Why? |
| Coated Materials, Biocompatible | 1 | 2017 | 113 | 0.16 | Why? |
| Incidence | 7 | 2020 | 25622 | 0.15 | Why? |
| Calcinosis | 1 | 2019 | 240 | 0.15 | Why? |
| Coronary Vessel Anomalies | 1 | 2017 | 87 | 0.15 | Why? |
| Equipment Failure | 1 | 2017 | 197 | 0.15 | Why? |
| Radiation Dosage | 2 | 2017 | 585 | 0.15 | Why? |
| Thrombosis | 1 | 2018 | 7504 | 0.15 | Why? |
| Stroke | 2 | 2021 | 8839 | 0.15 | Why? |
| Absorbable Implants | 1 | 2018 | 191 | 0.15 | Why? |
| Myocardial Reperfusion Injury | 1 | 2017 | 129 | 0.15 | Why? |
| Product Surveillance, Postmarketing | 1 | 2017 | 189 | 0.15 | Why? |
| Prosthesis Design | 1 | 2018 | 594 | 0.15 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.14 | Why? |
| Middle Aged | 27 | 2021 | 270681 | 0.14 | Why? |
| Aortic Aneurysm, Thoracic | 1 | 2017 | 161 | 0.14 | Why? |
| Blood Chemical Analysis | 1 | 2019 | 541 | 0.14 | Why? |
| Forecasting | 2 | 2019 | 4492 | 0.14 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 226 | 0.14 | Why? |
| California | 2 | 2019 | 2047 | 0.13 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.13 | Why? |
| Cataract | 1 | 2017 | 186 | 0.13 | Why? |
| Apolipoproteins A | 1 | 2012 | 19 | 0.13 | Why? |
| Follow-Up Studies | 5 | 2018 | 17020 | 0.13 | Why? |
| Pandemics | 14 | 2020 | 389249 | 0.13 | Why? |
| Aneurysm, Dissecting | 1 | 2017 | 303 | 0.12 | Why? |
| Thoracic Surgery | 1 | 2020 | 623 | 0.12 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.12 | Why? |
| Triage | 3 | 2020 | 7151 | 0.12 | Why? |
| Aortic Valve | 1 | 2019 | 664 | 0.12 | Why? |
| Time-to-Treatment | 2 | 2020 | 5883 | 0.12 | Why? |
| Fellowships and Scholarships | 1 | 2020 | 931 | 0.11 | Why? |
| Recurrence | 2 | 2021 | 3675 | 0.11 | Why? |
| Calcium | 1 | 2017 | 708 | 0.11 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.11 | Why? |
| Safety Management | 1 | 2020 | 1093 | 0.11 | Why? |
| North America | 3 | 2021 | 1400 | 0.11 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.11 | Why? |
| Occupational Health | 4 | 2020 | 3965 | 0.11 | Why? |
| Clinical Decision-Making | 3 | 2020 | 3755 | 0.11 | Why? |
| Patient Selection | 3 | 2020 | 4560 | 0.11 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.11 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.11 | Why? |
| Radiologists | 1 | 2017 | 873 | 0.11 | Why? |
| Patient Safety | 3 | 2020 | 4885 | 0.11 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.11 | Why? |
| Defibrillators, Implantable | 1 | 2017 | 624 | 0.10 | Why? |
| Aortic Valve Stenosis | 1 | 2019 | 741 | 0.10 | Why? |
| Patient Education as Topic | 1 | 2020 | 1476 | 0.10 | Why? |
| Pyrimidines | 1 | 2018 | 1557 | 0.10 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.10 | Why? |
| Shock, Cardiogenic | 1 | 2017 | 700 | 0.10 | Why? |
| Case-Control Studies | 3 | 2017 | 17671 | 0.10 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.10 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.10 | Why? |
| Carotid Artery Diseases | 1 | 2012 | 251 | 0.10 | Why? |
| Occupational Exposure | 2 | 2018 | 4742 | 0.09 | Why? |
| Electrocardiography | 2 | 2020 | 3957 | 0.09 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.09 | Why? |
| Heart-Assist Devices | 1 | 2017 | 812 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Acute Disease | 2 | 2017 | 6029 | 0.09 | Why? |
| Plaque, Atherosclerotic | 1 | 2012 | 423 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.08 | Why? |
| Stroke Volume | 1 | 2017 | 2153 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.08 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.08 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.08 | Why? |
| Workload | 1 | 2017 | 1887 | 0.08 | Why? |
| Tomography, Optical Coherence | 3 | 2018 | 1008 | 0.08 | Why? |
| Clinical Competence | 2 | 2020 | 3263 | 0.08 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.07 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.07 | Why? |
| Retrospective Studies | 6 | 2019 | 105322 | 0.07 | Why? |
| Atherosclerosis | 1 | 2012 | 768 | 0.07 | Why? |
| Russia | 2 | 2018 | 989 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.07 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.06 | Why? |
| Europe | 4 | 2018 | 12702 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 9706 | 0.05 | Why? |
| Epitopes | 1 | 2012 | 4113 | 0.05 | Why? |
| Severity of Illness Index | 5 | 2018 | 48226 | 0.05 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.05 | Why? |
| Internship and Residency | 1 | 2020 | 4987 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.05 | Why? |
| Reoperation | 1 | 2021 | 544 | 0.04 | Why? |
| Suction | 1 | 2020 | 297 | 0.04 | Why? |
| Rupture | 1 | 2017 | 40 | 0.04 | Why? |
| Radiation Monitoring | 1 | 2017 | 25 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Canada | 2 | 2021 | 6018 | 0.04 | Why? |
| Intra-Aortic Balloon Pumping | 1 | 2017 | 125 | 0.04 | Why? |
| Hospitals, Low-Volume | 1 | 2017 | 355 | 0.04 | Why? |
| Slit Lamp Microscopy | 1 | 2017 | 164 | 0.04 | Why? |
| Prevalence | 4 | 2018 | 25773 | 0.04 | Why? |
| Ambulatory Surgical Procedures | 1 | 2020 | 444 | 0.04 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.04 | Why? |
| Inservice Training | 1 | 2019 | 477 | 0.03 | Why? |
| Health Services | 1 | 2020 | 765 | 0.03 | Why? |
| Hospitals, High-Volume | 1 | 2017 | 688 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2020 | 781 | 0.03 | Why? |
| Checklist | 1 | 2019 | 714 | 0.03 | Why? |
| Hospital Units | 1 | 2020 | 1017 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Education, Medical, Continuing | 1 | 2019 | 638 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Visual Acuity | 1 | 2017 | 790 | 0.03 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.03 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.03 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.03 | Why? |
| Oxidation-Reduction | 1 | 2012 | 540 | 0.03 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.02 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.02 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2020 | 1876 | 0.02 | Why? |
| Operating Rooms | 1 | 2017 | 1841 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Health Status | 1 | 2019 | 3259 | 0.02 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Japan | 1 | 2017 | 6653 | 0.02 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |